260 related articles for article (PubMed ID: 28508572)
1. Clinical characteristics and factors associated with mortality in idiopathic pulmonary fibrosis: An experience from a tertiary care center in Pakistan.
Zubairi ABS; Ahmad H; Hassan M; Sarwar S; Abbas A; Shahzad T; Irfan M
Clin Respir J; 2018 Mar; 12(3):1191-1196. PubMed ID: 28508572
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
3. Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis.
Kärkkäinen M; Kettunen HP; Nurmi H; Selander T; Purokivi M; Kaarteenaho R
Respir Res; 2017 Aug; 18(1):160. PubMed ID: 28830514
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
[TBL] [Abstract][Full Text] [Related]
5. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard C; Hilberg O; Bendstrup E
Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
[TBL] [Abstract][Full Text] [Related]
6. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.
Kärkkäinen M; Nurmi H; Kettunen HP; Selander T; Purokivi M; Kaarteenaho R
BMC Pulm Med; 2018 May; 18(1):69. PubMed ID: 29751748
[TBL] [Abstract][Full Text] [Related]
7. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and prognosis of unclassifiable interstitial lung disease.
Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
[TBL] [Abstract][Full Text] [Related]
9. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
[TBL] [Abstract][Full Text] [Related]
10. Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study.
Yoon HY; Kim H; Bae Y; Song JW
Respir Res; 2024 Apr; 25(1):191. PubMed ID: 38685071
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
[TBL] [Abstract][Full Text] [Related]
12. The predictors of mortality in IPF - Does emphysema change the prognosis?
Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.
Mejía M; Carrillo G; Rojas-Serrano J; Estrada A; Suárez T; Alonso D; Barrientos E; Gaxiola M; Navarro C; Selman M
Chest; 2009 Jul; 136(1):10-15. PubMed ID: 19225068
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study.
Khor YH; Gutman L; Abu Hussein N; Johannson KA; Glaspole IN; Guler SA; Funke-Chambour M; Geiser T; Goh NSL; Ryerson CJ
Chest; 2021 Sep; 160(3):994-1005. PubMed ID: 33905679
[TBL] [Abstract][Full Text] [Related]
15. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
Tanaka S; Miyoshi K; Higo H; Kurosaki T; Otani S; Sugimoto S; Yamane M; Kiura K; Toyooka S; Oto T
Respir Investig; 2019 Mar; 57(2):165-171. PubMed ID: 30600175
[TBL] [Abstract][Full Text] [Related]
16. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis.
Kim WY; Mok Y; Kim GW; Baek SJ; Yun YD; Jee SH; Kim DS
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):289-96. PubMed ID: 25591140
[TBL] [Abstract][Full Text] [Related]
17. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
Sangani R; Ghio A; Culp S; Patel Z; Sharma S
Int J Chron Obstruct Pulmon Dis; 2021; 16():1873-1885. PubMed ID: 34188464
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
19. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?
Hashemi Sadraei N; Riahi T; Masjedi MR
Arch Iran Med; 2013 Mar; 16(3):177-81. PubMed ID: 23432171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
